Dr. Tabar is a founding investigator of BlueRock Therapeutics, a neurosurgeon and professor at Memorial Sloan Kettering Cancer Center in New York and holds a joint appointment at Weill Cornell Medical College in the departments of Neurosurgery and Neuroscience. Dr. Tabar is the director of the Neurosurgical Oncology fellowship program and the Theresa Feng Chair in Neurosurgery at MSKCC, and was recently appointed Chair of the Department of Neurosurgery. Her clinical practice is focused on the surgical management of brain and skull base tumors, with special emphasis on complex glioma surgery, intraoperative brain mapping, and pituitary tumors; she also directs the MSKCC multidisciplinary skull base and pituitary center.
Dr. Tabar serves as a co-PI of a large consortium grant aiming at the development of a clinical trial for grafting human embryonic stem cell–derived dopamine neurons in Parkinson patients and has focused major efforts on the development of human ES-derived oligodendrocytes for brain radiation damage.
Dr. Tabar received clinical training at the University of Massachusetts and at Memorial Sloan Kettering and research training at the National Institute of Neurological Disorders and Stroke/NIH.